MedPath

Effect of Nigella sativa oil on Prognosis of Acute Ischemic Stroke Patients

Not Applicable
Conditions
Acute ischemic stroke.
Cerebral infarction
Registration Number
IRCT20170112031893N4
Lead Sponsor
Ghoum University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
80
Inclusion Criteria

Acute ischemic stroke hospitalization in Shahid Beheshti hospital
Not having a severe disability after stroke(NIHSS<20)
Not to receive antioxidants (such as vitamin C and E) constantly
Not affected by AIDS and neurodegenerative diseases (e.g. Alzheimer's, Parkinson's, amyotrophic lateral sclerosis

Exclusion Criteria

Request of patients to Exit from the study;
Previous chronic disease interferes with the performance evaluation in patients such as: chronic infections, liver or kidney failure, cancers;
Residual weakness of previous stroke
Pregnancy or breastfeeding or any conditions that makes follow up impossible
Sever loss of Consciousness
Thrombolytic therapy
Endarterectomy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prognosis after stroke. Timepoint: At hospitalization(0), discharge(1), and after 3 months(2). Method of measurement: Functional status score based on NIHSS (National institutes of health stroke scale)(at least 50% reduction in NIHSS score in 3-month compared to the baseline score.
Secondary Outcome Measures
NameTimeMethod
Prognosis after stroke. Timepoint: At hospitalization(0), discharge(1), and after 3 months(2). Method of measurement: Modified Rankin scale (MRS).
© Copyright 2025. All Rights Reserved by MedPath